Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Sight Sciences Inc (SGHT)

Sight Sciences Inc (SGHT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Insider Sale: Director at $SGHT (SGHT) Sells 551,802 Shares

Staffan Encrantz, a director at $SGHT ($SGHT), sold 551,802 shares of the company on 11-21-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 46.6% of their...

SGHT : 4.01 (+6.65%)
Sight Sciences to Present at the Piper Sandler 36th Annual Healthcare Conference

SGHT : 4.01 (+6.65%)
Sight Sciences Reports Third Quarter 2024 Financial Results and Updates its Full Year 2024 Adjusted Operating Expense Guidance

SGHT : 4.01 (+6.65%)
Sight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, Operations

SGHT : 4.01 (+6.65%)
Sight Sciences to Report Third Quarter Financial Results on November 7, 2024

SGHT : 4.01 (+6.65%)
Single TearCare® Treatment Improved Functional Visual Outcomes as well as Signs and Symptoms of Patients with Dry Eye Disease in Investigator-Initiated Trial

SGHT : 4.01 (+6.65%)
Stock Index Futures Slip as Investors Brace for U.S. Inflation Data, Oracle Results Disappoint

September S&P 500 futures (ESU23) are down -0.23%, and September Nasdaq 100 E-Mini futures (NQU23) are down -0.26% this morning as market participants exercised caution and refrained from taking big positions...

ESU23 : 4,491.72s (-0.32%)
NQU23 : 15,435.20s (-0.28%)
TSLA : 352.56 (+3.80%)
QCOM : 156.79 (+0.86%)
TWNK : 33.30 (-0.15%)
RTX : 120.77 (+0.20%)
ORCL : 192.29 (-0.07%)
ABF.LN : 2,197.000 (+1.20%)
SGHT : 4.01 (+6.65%)
SLRN : 4.70 (+8.55%)
GERN : 4.07 (+1.24%)
AER : 98.03 (+0.32%)
3 Prime Healthcare Takeover Targets

These three companies are attractive targets for their potential.

CRSP : 47.88 (+3.43%)
BMRN : 64.26 (+1.28%)
SGHT : 4.01 (+6.65%)
VRTX : 450.97 (+0.13%)
Sight Sciences, Inc. (SGHT) Q2 2022 Earnings Call Transcript

SGHT earnings call for the period ending June 30, 2022.

SGHT : 4.01 (+6.65%)
Sight Sciences Announces the Appointment of Tamara Fountain, M.D. to its Board of Directors

MENLO PARK, Calif., July 19, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative...

SGHT : 4.01 (+6.65%)

Barchart Exclusives

3 High-Yielding Dividend Kings to Boost Your Income in 2025 and Beyond
These three high-quality companies are currently on sale, offering elevated yields that appeal to dividend growth investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar